Elena Vissio1, Enrico Costantino Falco1, Giammarco Collemi1, Fulvio Borella2, Mauro Papotti3, Antonio Scarmozzino4, Paola Cassoni1, Luca Bertero1. 1. Pathology Unit, Department of Medical Sciences, "Città della Salute e della Scienza di Torino" University Hospital, University of Turin, Turin, Italy. 2. Obstetrics, and Gynecology Unit, Department of Surgical Sciences, Sant'Anna Hospital, "Città della Salute e della Scienza di Torino" University Hospital, University of Turin, Turin, Italy. 3. Pathology Unit, Department of Oncology, "Città della Salute e della Scienza di Torino" University Hospital, University of Turin, Turin, Italy. 4. Healthcare Management, "Città della Salute e della Scienza di Torino" University Hospital, Turin, Italy.
Abstract
BACKGROUND AND OBJECTIVES: Italy was severely affected by the severe acute respiratory syndrome coronavirus 2 pandemic. Our Institution, Piedmont's largest tertiary referral center, was designated as a non-COVID-19 hospital and activities were reorganized to prioritize critical services like oncological care. The aim of this study was to investigate the efficacy in preserving the oncological surgical practice at our Institution during the most critical months of the COVID-19 epidemic by analyzing the surgical pathology activity. METHODS: The number of oncological surgical resections submitted to histopathological examination from 9th March 2020 to 8th May 2020 were collected as well staging/grading data and compared with the previous three pre-COVID-19 years (2017-2019). RESULTS: Overall, no decrease was observed for most tumor sites (5/9) while breast resections showed the largest drop (109 vs. 160; -31.9%), although a full recovery was already noticed during the second half of the period. Conversely, the selected control benchmarks showed a sharp decrease (-80.4%). Distribution of pathological TNM stages (or tumor grades for central nervous system tumors) showed no significant differences during the lockdown compared with previous years (p > .05). CONCLUSIONS: The present data suggest the possibility of preserving this cornerstone oncological activity during an evolving public health emergency thanks to a prompt workflow reorganization.
BACKGROUND AND OBJECTIVES: Italy was severely affected by the severe acute respiratory syndrome coronavirus 2 pandemic. Our Institution, Piedmont's largest tertiary referral center, was designated as a non-COVID-19 hospital and activities were reorganized to prioritize critical services like oncological care. The aim of this study was to investigate the efficacy in preserving the oncological surgical practice at our Institution during the most critical months of the COVID-19 epidemic by analyzing the surgical pathology activity. METHODS: The number of oncological surgical resections submitted to histopathological examination from 9th March 2020 to 8th May 2020 were collected as well staging/grading data and compared with the previous three pre-COVID-19 years (2017-2019). RESULTS: Overall, no decrease was observed for most tumor sites (5/9) while breast resections showed the largest drop (109 vs. 160; -31.9%), although a full recovery was already noticed during the second half of the period. Conversely, the selected control benchmarks showed a sharp decrease (-80.4%). Distribution of pathological TNM stages (or tumor grades for central nervous system tumors) showed no significant differences during the lockdown compared with previous years (p > .05). CONCLUSIONS: The present data suggest the possibility of preserving this cornerstone oncological activity during an evolving public health emergency thanks to a prompt workflow reorganization.
Authors: Y Loaiza-Aldeán; M de Miguel; V Morales-Ariza; A González-Tallada; S Manrique; J M Domínguez González; M de Nadal Journal: J Healthc Qual Res Date: 2022-03-07
Authors: M L F van Velthuysen; S van Eeden; S le Cessie; M de Boer; H van Boven; B M Koomen; F Roozekrans; J Bart; W Timens; Q J M Voorham Journal: BMC Health Serv Res Date: 2022-02-09 Impact factor: 2.655
Authors: P Gisondi; S Cazzaniga; S Di Leo; S Piaserico; F Bellinato; M Pizzolato; A Gatti; A Eccher; M Brunelli; D Saraggi; G Girolomoni; L Naldi Journal: J Eur Acad Dermatol Venereol Date: 2021-07-26 Impact factor: 9.228
Authors: Carlotta Micaela Jarach; Alessandra Lugo; Chiara Stival; Cristina Bosetti; Andrea Amerio; Luca Cavalieri d'Oro; Licia Iacoviello; Anna Odone; David Stuckler; Alberto Zucchi; Piet van den Brandt; Werner Garavello; Christopher R Cederroth; Winfried Schlee; Silvano Gallus Journal: Front Neurol Date: 2022-03-07 Impact factor: 4.003